San Antonio, TX2 Active Studies

Atrial Fibrillation Clinical Trials in San Antonio, TX

Find 2 actively recruiting atrial fibrillation clinical trials in San Antonio, TX. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
370
Enrolling

Recruiting Atrial Fibrillation Studies in San Antonio

About Atrial Fibrillation Clinical Trials in San Antonio

Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.

There are currently 2 atrial fibrillation clinical trials recruiting participants in San Antonio, TX. These studies are seeking a combined 370 participants. Research is being sponsored by CSL Behring, The University of Texas Health Science Center at San Antonio. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atrial Fibrillation Clinical Trials in San Antonio — FAQ

Are there atrial fibrillation clinical trials in San Antonio?

Yes, there are 2 atrial fibrillation clinical trials currently recruiting in San Antonio, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Antonio?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Antonio research site will contact you about next steps.

Are clinical trials in San Antonio free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Antonio studies also compensate for your time and travel.

What atrial fibrillation treatments are being tested?

The 2 active trials in San Antonio are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.

Data updated March 2, 2026 from ClinicalTrials.gov